Form 8-K - Current report:
SEC Accession No. 0001213900-15-009512
Filing Date
2015-12-16
Accepted
2015-12-16 16:09:43
Documents
2
Period of Report
2015-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121515_actiniumpharma.htm 8-K 14987
2 SECOND AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN, EFFECTIVE AS OF DE f8k121515ex10i_actiniumpha.htm EX-10.1 7474
  Complete submission text file 0001213900-15-009512.txt   23666
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 151291081
SIC: 2834 Pharmaceutical Preparations